查找临床试验
已按「斑秃」检索，对应国际通用词 alopecia areata
共找到 12 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 11:18，每 5 分钟自动同步Efficacy and Safety of JAK Inhibitors in Patients With AA: RWE Study
China
年龄 2 Years – 80 Years
Second Affiliated Hospital, Zhejiang University, School of Medicine
Alleviation of Alopecia in Breast Cancer Patient Using Synbiotics Formula
Hong Kong
年龄 18 Years – 60 Years
GenieBiome Limited
Multi-Omics Insights Into Androgenetic Alopecia
China
年龄 20 Years – 65 Years
The First Affiliated Hospital of Xinxiang Medical College
A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
United States、Canada、China、Netherlands、Poland 等 7 国
年龄 18 Years – 50 Years
Eli Lilly and Company
Exosome Therapy for Male Androgenetic Alopecia
China
年龄 18 Years – 55 Years
Zhang Han
Efficacy of Dihydroartemisinin for Treating Female Androgenetic Alopecia
China
年龄 18 Years – 40 Years
Shanghai Zhongshan Hospital
A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
United States、China、Czechia、France、Japan 等 6 国
年龄 6 Years – 14 Years
Pfizer
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
United States、Canada、China、Czechia、Japan 等 11 国
年龄 12 Years – 不限
Pfizer
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
United States、Argentina、Australia、Belgium、Brazil 等 12 国
年龄 12 Years – 63 Years
AbbVie
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
United States、Argentina、Australia、Canada、France 等 12 国
年龄 6 Years – 17 Years
Eli Lilly and Company
Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic Alopecia
China
年龄 18 Years – 不限
Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.
Topical Application of Lactobacillus Reuteri for Androgenetic Alopecia
China
年龄 18 Years – 60 Years
Shenzhen People's Hospital